Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2013
10/01/2013US8546442 Pyrazolopiperidine compounds as CCR1 receptor antagonists
10/01/2013US8546441 PDK-1/AKT signaling inhibitors
10/01/2013US8546440 Substituted bicyclic imidazole derivatives as gamma secretase modulators
10/01/2013US8546439 Small molecule inhibitors of retroviral assembly and maturation
10/01/2013US8546438 Substituted (thiophenyl-carbonyl)imidazolidinones, and use thereof
10/01/2013US8546437 Compounds and compositions and methods of use
10/01/2013US8546436 Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid and uses thereof
10/01/2013US8546435 Triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors
10/01/2013US8546434 Triazole compounds as KSP inhibitors
10/01/2013US8546433 Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer
10/01/2013US8546432 Tetrazolones as inhibitors of fatty acid synthase
10/01/2013US8546430 Thalidomide analogs
10/01/2013US8546429 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
10/01/2013US8546428 Fumarate salt of (alpha S, beta R)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
10/01/2013US8546427 Tetrahydroquinoline derivatives
10/01/2013US8546426 N-aminotetrahydroisoquinolines as anti-cancer agents
10/01/2013US8546425 Folate receptor binding conjugates of antifolates
10/01/2013US8546424 Acetylene derivatives of 5-phenyl-pyrazolopyridine, preparation thereof, and therapeutic use thereof
10/01/2013US8546423 Aerosolized fluoroquinolones and uses thereof
10/01/2013US8546421 Oncogenic-RAS-signal dependent lethal compounds
10/01/2013US8546420 4, 5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
10/01/2013US8546419 Dual phase drug release system
10/01/2013US8546418 Peripheral opioid receptor antagonists and uses thereof
10/01/2013US8546417 Fused and spirocycle compounds and the use thereof
10/01/2013US8546415 Bis-pyridino containing compounds for the use in the treatment of CNS pathologies
10/01/2013US8546414 Ion channel modulators and methods of use
10/01/2013US8546413 Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors
10/01/2013US8546412 Methods of treating heart failure
10/01/2013US8546411 Polymorphs of methyl (E)-2-{2-[6-(2-cyanophenoxy) pyrimidin-4-yloxy] phenyl}-3-methoxyacrylate
10/01/2013US8546410 Heteroaryl-fused macrocyclic pyrimidine derivatives
10/01/2013US8546409 Methods of treatment for solid tumors
10/01/2013US8546408 Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation
10/01/2013US8546407 Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitors
10/01/2013US8546406 Heterocyclic compounds as metap-2 inhibitors
10/01/2013US8546405 Anti-viral compounds
10/01/2013US8546403 Compounds that modulate intracellular calcium
10/01/2013US8546402 Chromone derivatives, a process for their preparation and their therapeutic applications
10/01/2013US8546401 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseases
10/01/2013US8546400 1,3-Oxazole-4-carboxamides, 1,3-Thiazole-4-carboxamides, and 1,3-Imidazole-d-carboxamides as Inhibitors of cyclin Dependent kinases
10/01/2013US8546399 Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
10/01/2013US8546398 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
10/01/2013US8546397 DNA methylation inhibitors
10/01/2013US8546396 N-(hetero)aryl, 2-(hetero)aryl—substituted acetamides for use as Wnt signaling modulators
10/01/2013US8546395 6-cycloamino-3-(1H-pyrrolo[2,3-b]pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof
10/01/2013US8546394 Substituted [1,2,4]triazolo[4,3-A]pyrazine 11-beta-hydroxysteroid dehydrogenase inhibitors
10/01/2013US8546393 6-triazolopyridazine sulfanyl benzothiazole derivatives as MET inhibitors
10/01/2013US8546392 17Beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseases
10/01/2013US8546391 Thiadiazole and oxadiazole derivatives, preparation thereof and therapeutic use thereof
10/01/2013US8546390 6-(pyrrolopyridinyl) pyrimidin-2-ylamine derivatives and the use thereof for the treatment of cancer and AIDS
10/01/2013US8546389 Viral polymerase inhibitors
10/01/2013US8546388 Heterocyclic TRPV1 receptor ligands
10/01/2013US8546387 Pyrido[2,3-b]pyrazin-8-substituted compounds and their use
10/01/2013US8546386 Corrosion and microbial control in hydrocarbonaceous compositions
10/01/2013US8546385 Benzoic pyrrolopyridine derivatives
10/01/2013US8546384 Bonding tissues and cross-linking proteins with naphthalimide compounds
10/01/2013US8546383 Chiral fused [1,2]imidazo[4,5-c] ring compounds
10/01/2013US8546382 Methods for enhancing hematopoietic progenitor cell engraftment
10/01/2013US8546381 Bridged heterocyclic compounds and methods of use
10/01/2013US8546380 Aminodihydrothiazine derivatives
10/01/2013US8546379 5HT2C receptor modulators
10/01/2013US8546378 5HT2C receptor modulator compositions and methods of use
10/01/2013US8546377 Modulators of 5-HT receptors and methods of use thereof
10/01/2013US8546376 Pharmaceutical compounds
10/01/2013US8546375 (3-(4-(aminomethyl)phenoxy or phenylthio)azetidin-1-yl)(5-phenyl-1,3,4-oxadiazol-2-yl)methanone compounds
10/01/2013US8546374 Amino-tetrazoles analogues and methods of use
10/01/2013US8546373 Methods of sensitizing drug resistant microorganisms using methylsulfonylmethane (MSM)
10/01/2013US8546372 Methods of treating hypertriglyceridemia
10/01/2013US8546371 Nanoparticle formulated glycolipid antigens for immunotherapy
10/01/2013US8546370 Compounds and compositions as kinase inhibitors
10/01/2013US8546369 Salts of creatine imino sugar amides
10/01/2013US8546368 Pyrazoloquinolones are potent PARP inhibitors
10/01/2013US8546367 Synthetic bile acid compositions and methods
10/01/2013US8546366 Method for inhibition of tumor cell growth using (22R)-5α-lanosta-8,24-dien-3β,15α,21-triol
10/01/2013US8546365 Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
10/01/2013US8546364 Stabilized steroid composition and method for its preparation
10/01/2013US8546363 Controlled release corticosteroid compositions and methods for the treatment of otic disorders
10/01/2013US8546362 Medicinal cream made using neomycin sulphate, betamethasone valerate, and chitosan, and a process to make the same
10/01/2013US8546361 Pseudolipid complex mixture and a skin external application composition containing same
10/01/2013US8546358 Method of treating asthma
10/01/2013US8546357 Boron-containing small molecules for controlling ectoparasites
10/01/2013US8546356 Administration form of osteogenic protein complexes
10/01/2013US8546355 Compositions comprising cyclodextrin
10/01/2013US8546354 Acylated decasaccharides and their use as antithrombotic agents
10/01/2013US8546353 Compounds and combinations
10/01/2013US8546352 Pharmacological preparation for topical use containing N-palmitoyl-vanillamide
10/01/2013US8546351 Hypersulfated disaccharide formulations
10/01/2013US8546350 Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
10/01/2013US8546344 Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl)-1H-benzimidazole
10/01/2013US8546343 Aminoglycoside antibiotics targeting bacterial 16S ribosomal RNA
10/01/2013US8546342 Composition for treating mental health disorders
10/01/2013US8546341 Compositions and methods for treating bruises
10/01/2013US8546322 Inhibitors of intracellular urokinase plasminogen activator and methods of use thereof
10/01/2013US8546305 Active compound combinations
10/01/2013US8546304 Composition and method for improving plant health
10/01/2013US8546143 Compositions and methods for inhibiting expression of a target gene
10/01/2013US8546091 AKT phosphorylation at Ser473 as an indicator for taxane-based chemotherapy
10/01/2013US8545897 Pyrrolopyridines as kinase inhibitors
10/01/2013US8545889 Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
10/01/2013US8545887 Modified release dosage forms
10/01/2013US8545886 Extended release tablet formulations of flibanserin and method for manufacturing the same
1 ... 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 ... 7860